More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
In patients with cirrhosis, particularly those with hepatocellular carcinoma (HCC), hypercoagulability may be associated with purported increased risks of portal vein thrombosis and cirrhosis progression. In this study, we extensively investigated hemostatic alterations potentially responsible for t...
Guardado en:
Autores principales: | Alberto Zanetto, Elena Campello, Cristiana Bulato, Sabrina Gavasso, Graziella Saggiorato, Sarah Shalaby, Luca Spiezia, Umberto Cillo, Fabio Farinati, Francesco Paolo Russo, Patrizia Burra, Marco Senzolo, Paolo Simioni |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ce61a024a8ea4e6885ee7bbc5be7988e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development and application of global assays of hyper‐ and hypofibrinolysis
por: Anton Ilich, et al.
Publicado: (2020) -
Influence of the CXCL1 rs4074 A allele on alcohol induced cirrhosis and HCC in patients of European descent.
por: Hans Dieter Nischalke, et al.
Publicado: (2013) -
Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus
por: Fadwa A. Abdelwahab, et al.
Publicado: (2020) -
Serum hypercoagulability states in Coats’ disease
por: Ghassemi F, et al.
Publicado: (2017) -
Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation
por: Laura Crocetti, et al.
Publicado: (2021)